This work presents a flexible synthesis of 10 novel naphthoquinone–chalcone
derivatives (
1
–
10
) by nucleophilic
substitution of readily accessible aminochalcones and 2,3-dichloro-1,4-naphthoquinone.
All compounds displayed broad-spectrum cytotoxic activities against
all the tested cancer cell lines (i.e., HuCCA-1, HepG2, A549, MOLT-3,
T47D, and MDA-MB-231) with IC
50
values in the range of
0.81–62.06 μM, especially the four most potent compounds
1
,
3
,
8
, and
9
. The
in vitro
investigation on the fibroblast growth factor receptor
1 (FGFR1) inhibitory effect indicated that eight derivatives (
1
–
2
,
4
–
5
, and
7
–
10
) were active FGFR1 inhibitors
(IC
50
= 0.33–3.13 nM) with more potency than that
of the known FGFR1 inhibitor, AZD4547 (IC
50
= 12.17 nM).
Promisingly, compounds
5
(IC
50
= 0.33 ±
0.01 nM),
9
(IC
50
= 0.50 ± 0.04 nM),
and
7
(IC
50
= 0.85 ± 0.08 nM) were the
three most potent FGFR1 inhibitors. Molecular docking, molecular dynamics
simulations, and MM/GBSA-based free energy calculation revealed that
the key amino acid residues involved in the binding of the compounds
5
,
7
, and
9
and the target FGFR1
protein were similar with those of the AZD4547 (i.e., Val492, Lys514,
Ile545, Val561, Ala640, and Asp641). These findings revealed that
the newly synthesized naphthoquinone–chalcone scaffold is a
promising structural feature for an efficient inhibition of FGFR1.